Chikungunya is a mosquito-borne viral disease that results in fever and severe joint pain. The symptoms developed after the bite of 4 to 6 days in humans and the mosquitos bite usually during daytime and outdoors.
This report contains market size and forecasts of Chikungunya Rapid Testing in Global, including the following market information:
Global Chikungunya Rapid Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Chikungunya Rapid Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Serological Testing Techniques Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Chikungunya Rapid Testing include Quest Diagnostics, Alere, Genome Diagnostics, Bio-Rad Laboratories, Sanat Products, Taj Pharmaceuticals, Inbios India, Medical Innovation Ventures (Mediven) and Lumiquick Diagnostics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Chikungunya Rapid Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Chikungunya Rapid Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Chikungunya Rapid Testing Market Segment Percentages, by Type, 2021 (%)
Serological Testing Techniques
Molecular Testing Techniques
Global Chikungunya Rapid Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Chikungunya Rapid Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Academic Institutes
Diagnostic Centres
Biotechnology Companies
Other
Global Chikungunya Rapid Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Chikungunya Rapid Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Chikungunya Rapid Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Chikungunya Rapid Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Quest Diagnostics
Alere
Genome Diagnostics
Bio-Rad Laboratories
Sanat Products
Taj Pharmaceuticals
Inbios India
Medical Innovation Ventures (Mediven)
Lumiquick Diagnostics
Etubics Corporation
CTK Biotech